A new mega-merger deal was confirmed this week in the cannabis space.

Meanwhile, a Canadian cannabis producer announced more cuts to its operations, along with reductions in its staff, in a bid to improve its operational balance.


Keep reading to find out more cannabis highlights from the past five days.

Two cannabis producers announce intention to join forces

2020 was expected to be exemplified by mergers and acquisitions, and Aphria (NASDAQ:APHA,TSX:APHA) and Tilray (NASDAQ:TLRY) brought it down to the wire.

Under a newly announced merger deal, the two companies will join up, retaining the Tilray name and as well as Tilray’s stock symbol. However, Aphria CEO Irwin Simon will lead the entire operation, while Brendan Kennedy, CEO of Tilray, will become a board member.

According to estimations from the two companies, the resulting entity will hold a market valuation of C$5 billion and will post a combined C$900 million in pro forma revenue in 2020.

After the deal was confirmed, a panel of experts in the cannabis industry gathered to discuss the next steps for the market at large — but not before clamoring for more deals like the Aphria/Tilray tie up.

“(Tuesday’s) announcement is something that we’ve been suggesting for some time, (something) I think the industry needs and has been looking for, which is consolidation amongst the many operators that do sit in Canada,” Som Seif, founder and CEO of Purpose Financial, told an online audience.

The deal is expected to close sometime in Q2 of the 2021 calendar year.

Even more cuts seen in the Canadian cannabis space

A week after the latest round of cuts from cannabis producer Canopy Growth (NASDAQ:CGC,TSX:WEED), it is now Aurora Cannabis’ (NYSE:ACB,TSX:ACB) turn.

An Aurora spokesperson confirmed to CBC that 214 workers will be dismissed for a proposed 75 percent reduction in operations at the company’s Aurora Sky facility in Edmonton, Alberta.

Miguel Martin, CEO of Aurora, said in a statement that some of the company’s previous cost-saving moves are already paying off. He said scaling back production at the Aurora Sky facility will make it so this space can transform into a “high-value cultivation center for our premium strains, and in turn, better align production with current demand for premium flower.”

After confirming an undisclosed agreement with its credit facility lenders, the company told investors that as of Tuesday (December 15) it held $450 million in cash.

Cannabis company news

  • Halo Labs (NEO:HALO,OTCQX:AGEEF) shared an update on a financing program through which the company sold 134,454,000 shares for gross proceeds of C$7 million.
  • Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) issued its Q3 financial results, highlighting C$1.2 million in positive adjusted EBITDA and sequential growth in revenue of 15.8 percent from the previous quarter.
  • VIVO Cannabis (TSX:VIVO,OTCQX:VVCIF) confirmed that a selection of its medical cannabis products in Canada are now available through the Medical Cannabis by Shoppers online platform.
  • AMP German Cannabis Group (CSE:XCX) sent a letter to shareholders evaluating its operating year highlights in the German cannabis market and what may be on the way in 2021.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less